Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 703

1.

Health-related quality of life among patients with comorbid diabetes and kidney disease attending a codesigned integrated model of care: a longitudinal study.

Zimbudzi E, Lo C, Ranasinha S, Teede H, Usherwood T, Polkinghorne KR, Fulcher G, Gallagher M, Jan S, Cass A, Walker R, Russell G, Johnson G, Kerr PG, Zoungas S.

BMJ Open Diabetes Res Care. 2020 Jan;8(1). pii: e000842. doi: 10.1136/bmjdrc-2019-000842.

2.

Performance of cardiovascular risk prediction equations in Indigenous Australians.

Barr ELM, Barzi F, Rohit A, Cunningham J, Tatipata S, McDermott R, Hoy WE, Wang Z, Bradshaw PJ, Dimer L, Thompson PL, Brimblecombe J, O'Dea K, Connors C, Burgess P, Guthridge S, Brown A, Cass A, Shaw JE, Maple-Brown L.

Heart. 2020 Jan 16. pii: heartjnl-2019-315889. doi: 10.1136/heartjnl-2019-315889. [Epub ahead of print]

PMID:
31949024
3.

Sn-modification of Pt7/alumina model catalysts: Suppression of carbon deposition and enhanced thermal stability.

Li G, Zandkarimi B, Cass AC, Gorey TJ, Allen BJ, Alexandrova AN, Anderson SL.

J Chem Phys. 2020 Jan 14;152(2):024702. doi: 10.1063/1.5129686.

PMID:
31941332
4.

Qualitative study of psychosocial factors impacting on Aboriginal women's management of chronic disease.

Eades A, Hackett ML, Liu H, Brown A, Coffin J, Cass A.

Int J Equity Health. 2020 Jan 13;19(1):8. doi: 10.1186/s12939-019-1110-3.

5.

My experiences with kidney care: A qualitative study of adults in the Northern Territory of Australia living with chronic kidney disease, dialysis and transplantation.

Hughes JT, Freeman N, Beaton B, Puruntatemeri AM, Hausin M, Tipiloura G, Wood P, Signal S, Majoni SW, Cass A, Maple-Brown LJ, Kirkham R.

PLoS One. 2019 Dec 19;14(12):e0225722. doi: 10.1371/journal.pone.0225722. eCollection 2019.

6.

Transposable element expression in tumors is associated with immune infiltration and increased antigenicity.

Kong Y, Rose CM, Cass AA, Williams AG, Darwish M, Lianoglou S, Haverty PM, Tong AJ, Blanchette C, Albert ML, Mellman I, Bourgon R, Greally J, Jhunjhunwala S, Chen-Harris H.

Nat Commun. 2019 Nov 19;10(1):5228. doi: 10.1038/s41467-019-13035-2.

7.

Hospitalized fracture rates amongst patients with chronic kidney disease in Australia using data linkage.

Lin R, Toussaint ND, Gallagher M, Cass A, Kotwal S.

Nephrology (Carlton). 2019 Nov 19. doi: 10.1111/nep.13681. [Epub ahead of print]

PMID:
31743530
8.

Varying Association of Extended Hours Dialysis with Quality of Life.

Smyth B, van den Broek-Best O, Hong D, Howard K, Rogers K, Zuo L, Gray NA, de Zoysa JR, Chan CT, Lin H, Zhang L, Xu J, Cass A, Gallagher M, Perkovic V, Jardine M.

Clin J Am Soc Nephrol. 2019 Dec 6;14(12):1751-1762. doi: 10.2215/CJN.06800619. Epub 2019 Oct 31.

PMID:
31672793
9.

Protocol for the Study of Heart and Renal Protection-Extended Review: Additional 5-Year Follow-up of the Australian, New Zealand, and Malaysian SHARP Cohort.

Sukkar L, Talbot B, Jun M, Dempsey E, Walker R, Hooi L, Cass A, Jardine M, Gallagher M.

Can J Kidney Health Dis. 2019 Oct 14;6:2054358119879896. doi: 10.1177/2054358119879896. eCollection 2019.

10.

mountainClimber Identifies Alternative Transcription Start and Polyadenylation Sites in RNA-Seq.

Cass AA, Xiao X.

Cell Syst. 2019 Oct 23;9(4):393-400.e6. doi: 10.1016/j.cels.2019.07.011. Epub 2019 Sep 18.

PMID:
31542416
11.

The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative study.

Zimbudzi E, Lo C, Robinson T, Ranasinha S, Teede HJ, Usherwood T, Polkinghorne KR, Kerr PG, Fulcher G, Gallagher M, Jan S, Cass A, Walker R, Russell G, Johnson G, Zoungas S.

PLoS One. 2019 Jul 15;14(7):e0219685. doi: 10.1371/journal.pone.0219685. eCollection 2019.

12.

Deep evolutionary origin of limb and fin regeneration.

Darnet S, Dragalzew AC, Amaral DB, Sousa JF, Thompson AW, Cass AN, Lorena J, Pires ES, Costa CM, Sousa MP, Fröbisch NB, Oliveira G, Schneider PN, Davis MC, Braasch I, Schneider I.

Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15106-15115. doi: 10.1073/pnas.1900475116. Epub 2019 Jul 3.

13.

Cost of dialysis therapies in rural and remote Australia - a micro-costing analysis.

Gorham G, Howard K, Zhao Y, Ahmed AMS, Lawton PD, Sajiv C, Majoni SW, Wood P, Conlon T, Signal S, Robinson SL, Brown S, Cass A.

BMC Nephrol. 2019 Jun 25;20(1):231. doi: 10.1186/s12882-019-1421-z.

14.

Aboriginal and Torres Strait Islander people's domains of wellbeing: A comprehensive literature review.

Butler TL, Anderson K, Garvey G, Cunningham J, Ratcliffe J, Tong A, Whop LJ, Cass A, Dickson M, Howard K.

Soc Sci Med. 2019 Jul;233:138-157. doi: 10.1016/j.socscimed.2019.06.004. Epub 2019 Jun 5. Review.

PMID:
31200269
15.

Acute kidney injury in Indigenous Australians: an unrecognised priority for action.

Cass A, Hughes JT.

Med J Aust. 2019 Jul;211(1):14-15. doi: 10.5694/mja2.50232. Epub 2019 Jun 10. No abstract available.

PMID:
31179541
16.

Polyfunctionalised Nanoparticles Bearing Robust Gadolinium Surface Units for High Relaxivity Performance in MRI.

Chabloz NG, Wenzel MN, Perry HL, Yoon IC, Molisso S, Stasiuk GJ, Elson DS, Cass AEG, Wilton-Ely JDET.

Chemistry. 2019 Aug 14;25(46):10895-10906. doi: 10.1002/chem.201901820. Epub 2019 Jul 17.

PMID:
31127668
17.

Impact of Supplemental Private Health Insurance on Dialysis and Outcomes.

Sriravindrarajah A, Kotwal SS, Sen S, McDonald S, Jardine M, Cass A, Gallagher M.

Intern Med J. 2019 May 20. doi: 10.1111/imj.14375. [Epub ahead of print]

PMID:
31111611
18.

HMG-CoA reductase inhibitors (statins) and acute kidney injury: A secondary analysis of renal study outcomes.

Wang AY, Trongtrakul K, Bellomo R, Li Q, Cass A, Gallagher M; RENAL Study Investigators and the ANZICS Clinical Trials Group.

Nephrology (Carlton). 2019 Sep;24(9):912-918. doi: 10.1111/nep.13597. Epub 2019 May 27.

PMID:
31058387
19.

Incident haemodialysis and outcomes in the Top End of Australia.

Hughes JT, Majoni SW, Barzi F, Harris TM, Signal S, Lowah G, Kapojos J, Abeyaratne A, Sundaram M, Goldrick P, Jones SL, McFarlane R, Campbell LT, Stephens D, Cass A.

Aust Health Rev. 2019 Apr 18. doi: 10.1071/AH18230. [Epub ahead of print]

PMID:
30995950
20.

Development of a Minimally Invasive Microneedle-Based Sensor for Continuous Monitoring of β-Lactam Antibiotic Concentrations in Vivo.

Gowers SAN, Freeman DME, Rawson TM, Rogers ML, Wilson RC, Holmes AH, Cass AE, O'Hare D.

ACS Sens. 2019 Apr 26;4(4):1072-1080. doi: 10.1021/acssensors.9b00288. Epub 2019 Apr 17.

PMID:
30950598
21.

Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.

Viecelli AK, Polkinghorne KR, Pascoe EM, Paul-Brent PA, Hawley CM, Badve SV, Cass A, Hooi LS, Kerr PG, Mori TA, Ong LM, Voss D, Johnson DW, Irish AB; Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

PLoS One. 2019 Mar 26;14(3):e0213274. doi: 10.1371/journal.pone.0213274. eCollection 2019.

22.

Is hyperfiltration associated with higher urine albumin-to-creatinine ratio at follow up among Indigenous Australians? The eGFR follow-up study.

Ekinci EI, Barr ELM, Barzi F, Hughes JT, Lawton PD, Jones GRD, Hoy W, Cass A, Thomas M, Sinha A, Jerums G, O'Dea K, MacIsaac RJ, Maple-Brown LJ.

J Diabetes Complications. 2019 May;33(5):343-349. doi: 10.1016/j.jdiacomp.2019.02.005. Epub 2019 Feb 21.

PMID:
30904420
23.

Laparoscopic fluorescence image-guided photothermal therapy enhances cancer diagnosis and treatment.

Singh M, Nabavi E, Zhou Y, Gallina ME, Zhao H, Ruenraroengsak P, Porter AE, Ma D, Cass AEG, Hanna GB, Elson DS.

Nanotheranostics. 2019 Jan 29;3(1):89-102. doi: 10.7150/ntno.28585. eCollection 2019.

24.

Microneedle Array-Based Platforms for Future Theranostic Applications.

Howells O, Rajendran N, Mcintyre S, Amini-Asl S, Henri P, Liu Y, Guy O, Cass AEG, Morris MC, Sharma S.

Chembiochem. 2019 Sep 2;20(17):2198-2202. doi: 10.1002/cbic.201900112. Epub 2019 Jun 24.

PMID:
30897259
25.

Nanoneedle-Mediated Stimulation of Cell Mechanotransduction Machinery.

Hansel CS, Crowder SW, Cooper S, Gopal S, João Pardelha da Cruz M, de Oliveira Martins L, Keller D, Rothery S, Becce M, Cass AEG, Bakal C, Chiappini C, Stevens MM.

ACS Nano. 2019 Mar 26;13(3):2913-2926. doi: 10.1021/acsnano.8b06998. Epub 2019 Mar 4.

26.

Measuring luteinising hormone pulsatility with a robotic aptamer-enabled electrochemical reader.

Liang S, Kinghorn AB, Voliotis M, Prague JK, Veldhuis JD, Tsaneva-Atanasova K, McArdle CA, Li RHW, Cass AEG, Dhillo WS, Tanner JA.

Nat Commun. 2019 Feb 20;10(1):852. doi: 10.1038/s41467-019-08799-6.

27.

Quality of life in caregivers compared with dialysis recipients: The Co-ACTIVE sub-study of the ACTIVE dialysis trial.

Gray NA, Zuo L, Hong D, Smyth B, Jun M, De Zoysa J, Vo K, Howard K, Wang J, Lu C, Liu Z, Cass A, Perkovic V, Jardine M.

Nephrology (Carlton). 2019 Oct;24(10):1056-1063. doi: 10.1111/nep.13530. Epub 2019 Apr 29.

PMID:
30723975
28.

Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney disease.

Lo C, Zimbudzi E, Teede HJ, Kerr PG, Ranasinha S, Cass A, Fulcher G, Gallagher M, Polkinghorne KR, Russell G, Usherwood T, Walker R, Zoungas S.

J Diabetes Complications. 2019 Jan;33(1):63-68. doi: 10.1016/j.jdiacomp.2018.09.020. Epub 2018 Oct 12.

PMID:
30621853
29.

Wellbeing intervention for chronic kidney disease (WICKD): a randomised controlled trial study protocol.

Dingwall KM, Nagel T, Hughes JT, Kavanagh DJ, Cass A, Howard K, Sweet M, Brown S, Sajiv C, Majoni SW.

BMC Psychol. 2019 Jan 8;7(1):2. doi: 10.1186/s40359-018-0264-x.

30.

Incorporating indigenous knowledge in health services: a consumer partnership framework.

Kirkham R, Maple-Brown LJ, Freeman N, Beaton B, Lamilami R, Hausin M, Puruntatemeri AM, Wood P, Signal S, Majoni SW, Cass A, Hughes JT.

Public Health. 2019 Nov;176:159-162. doi: 10.1016/j.puhe.2018.08.009. Epub 2018 Oct 24.

PMID:
30528543
31.

Development of drug-loaded protein nanoparticles displaying enzymatically-conjugated DNA aptamers for cancer cell targeting.

Mie M, Matsumoto R, Mashimo Y, Cass AEG, Kobatake E.

Mol Biol Rep. 2019 Feb;46(1):261-269. doi: 10.1007/s11033-018-4467-2. Epub 2018 Nov 12.

32.

Electric Single-Molecule Hybridization Detector for Short DNA Fragments.

Loh AYY, Burgess CH, Tanase DA, Ferrari G, McLachlan MA, Cass AEG, Albrecht T.

Anal Chem. 2018 Dec 4;90(23):14063-14071. doi: 10.1021/acs.analchem.8b04357. Epub 2018 Nov 15.

33.

Sex and mortality in septic severe acute kidney injury.

O'Brien Z, Cass A, Cole L, Finfer S, Gallagher M, McArthur C, McGuiness S, Myburgh J, Bellomo R, Mårtensson J; RENAL Study Investigators and the Australian and New Zealand Intensive Care Clinical Trials Group.

J Crit Care. 2019 Feb;49:70-76. doi: 10.1016/j.jcrc.2018.10.017. Epub 2018 Oct 23.

PMID:
30388491
34.

Infusion reactions following administration of intravenous rolapitant at an academic medical center.

Cass AS, Odinet JS, Valgus JM, Crona DJ.

J Oncol Pharm Pract. 2019 Oct;25(7):1776-1783. doi: 10.1177/1078155218808084. Epub 2018 Oct 22.

PMID:
30348072
35.

Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

Lo C, Toyama T, Wang Y, Lin J, Hirakawa Y, Jun M, Cass A, Hawley CM, Pilmore H, Badve SV, Perkovic V, Zoungas S.

Cochrane Database Syst Rev. 2018 Sep 24;9:CD011798. doi: 10.1002/14651858.CD011798.pub2. Review.

36.

Disparity of access to kidney transplantation by Indigenous and non-Indigenous Australians.

Khanal N, Lawton PD, Cass A, McDonald SP.

Med J Aust. 2018 Sep 17;209(6):261-266. Erratum in: Med J Aust. 2018 Dec 10;209(11):475.

PMID:
30208818
37.

Microneedle-based biosensor for minimally-invasive lactate detection.

Bollella P, Sharma S, Cass AEG, Antiochia R.

Biosens Bioelectron. 2019 Jan 1;123:152-159. doi: 10.1016/j.bios.2018.08.010. Epub 2018 Aug 10.

PMID:
30177422
38.

Public acceptability of computer-controlled antibiotic management: An exploration of automated dosing and opportunities for implementation.

Rawson TM, Ming D, Gowers SA, Freeman DM, Herrero P, Georgiou P, Cass AE, O'Hare D, Holmes AH.

J Infect. 2019 Jan;78(1):75-86. doi: 10.1016/j.jinf.2018.08.005. Epub 2018 Aug 10.

39.

Can economic incentives increase the use of home dialysis?

Manns B, Agar JWM, Biyani M, Blake PG, Cass A, Culleton B, Kleophas W, Komenda P, Lobbedez T, MacRae J, Marshall MR, Scott-Douglas N, Srivastava V, Magner P.

Nephrol Dial Transplant. 2019 May 1;34(5):731-741. doi: 10.1093/ndt/gfy223.

PMID:
30010852
40.

Decolourization and biodegradation of azo dye methyl red by Rhodococcus strain UCC 0016.

Maniyam MN, Ibrahim AL, Cass AEG.

Environ Technol. 2020 Jan;41(1):71-85. doi: 10.1080/09593330.2018.1491634. Epub 2018 Jun 28.

PMID:
29923786
41.

Impact of CKD on Household Income.

Morton RL, Schlackow I, Gray A, Emberson J, Herrington W, Staplin N, Reith C, Howard K, Landray MJ, Cass A, Baigent C, Mihaylova B; SHARP Collaborative Group.

Kidney Int Rep. 2017 Dec 23;3(3):610-618. doi: 10.1016/j.ekir.2017.12.008. eCollection 2018 May.

42.

Analysis of Opioid Use Following Curative Cancer Treatment at a Large Urban Safety-net Hospital.

Cass AS, Alese JT, Kim C, Curry MA, LaFollette JA, Chen Z, Alese OB.

Clin J Pain. 2018 Oct;34(10):885-889. doi: 10.1097/AJP.0000000000000612.

PMID:
29578885
43.

Gathering Perspectives - Finding Solutions for Chronic and End Stage Kidney Disease.

Hughes JT, Dembski L, Kerrigan V, Majoni SW, Lawton PD, Cass A.

Nephrology (Carlton). 2018 Feb;23 Suppl 1:5-13. doi: 10.1111/nep.13233. No abstract available.

PMID:
29436104
44.

Models of care for co-morbid diabetes and chronic kidney disease.

Lo C, Zimbudzi E, Teede H, Cass A, Fulcher G, Gallagher M, Kerr PG, Jan S, Johnson G, Mathew T, Polkinghorne K, Russell G, Usherwood T, Walker R, Zoungas S.

Nephrology (Carlton). 2018 Aug;23(8):711-717. doi: 10.1111/nep.13232. Review.

PMID:
29405503
45.

High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.

Barr ELM, Barzi F, Hughes JT, Jerums G, Hoy WE, O'Dea K, Jones GRD, Lawton PD, Brown ADH, Thomas M, Ekinci EI, Sinha A, Cass A, MacIsaac RJ, Maple-Brown LJ.

Diabetes Care. 2018 Apr;41(4):739-747. doi: 10.2337/dc17-1919. Epub 2018 Jan 24.

PMID:
29367427
46.

Trajectories of eGFR decline over a four year period in an Indigenous Australian population at high risk of CKD-the eGFR follow up study.

Barzi F, Jones GRD, Hughes JT, Lawton PD, Hoy W, O'Dea K, Jerums G, MacIsaac RJ, Cass A, Maple-Brown LJ.

Clin Biochem. 2018 Mar;53:58-64. doi: 10.1016/j.clinbiochem.2018.01.011.

PMID:
29366878
47.
48.

A systematic review of adherence in Indigenous Australians: an opportunity to improve chronic condition management.

de Dassel JL, Ralph AP, Cass A.

BMC Health Serv Res. 2017 Dec 27;17(1):845. doi: 10.1186/s12913-017-2794-y. Review.

49.

Cross-sectional associations of albuminuria among Aboriginal and Torres Strait Islander adults: the eGFR Study.

Hughes JT, Maple-Brown LJ, Thomas M, Lawton PD, Sinha A, Cass A, Barzi F, Jones G, Jerums G, MacIsaac RJ, O'Dea K, Hoy WE.

Nephrology (Carlton). 2018 Jan;23(1):37-45. doi: 10.1111/nep.12956.

PMID:
29250918
50.

Delivering precision antimicrobial therapy through closed-loop control systems.

Rawson TM, O'Hare D, Herrero P, Sharma S, Moore LSP, de Barra E, Roberts JA, Gordon AC, Hope W, Georgiou P, Cass AEG, Holmes AH.

J Antimicrob Chemother. 2018 Apr 1;73(4):835-843. doi: 10.1093/jac/dkx458. Review.

Supplemental Content

Support Center